Specific instruments to evaluate their knowledge of asthma: a systematic review

Introduction: The evaluation of the level of asthma knowledge is one of the major outcomes for studies related to educational programs on asthma. Hence, identifying the particular instrument suitable for this outcome is essential to the success of studies in this field. Objective: To identify specific instruments to assess knowledge of asthma, analyzing the main characteristics and quality criteria for psychometric validation. Methods: A systematic review was performed to identify outcome measures available to assess knowledge of asthma in children, adolescents, guardians and caregivers. We applied the logic of search in Medline, Lilacs, Scopus, DirectScience, PsycINFO, Cochrane and Tripdatabase. Articles were included by description of the development and psychometric testing of the questionnaires on asthma knowledge. Quality criteria for content validity, construct validity, internal consistency and reproducibility were evaluated and assigned as “positive”, “intermediate” or “negative” rating. Results: Twenty-two instruments were included in the study. None of them had a positive review for all four evaluated psychometric properties. Six received positive or intermediate classification, one of these was developed in Portuguese-BR. Conclusion: Currently, there are 22 questionnaires available to assess the level of asthma knowledge, but most of the instruments do not have full psychometric validationIntrodução: a avaliação do nível de conhecimento em asma é um dos principais desfechos para estudos vinculados a programas de educação em asma. Para isso, identificar o instrumento específico adequado para tal desfecho é essencial para o sucesso de pesquisas nessa área. Objetivo: identificar instrumentos específicos para avaliar o conhecimento de asma, analisando as características principais e os crité- rios de qualidade para validação psicométrica. Métodos: uma revisão sistemática foi realizada para identificar medidas de resultados disponíveis para avaliar o conhecimento da asma em crianças, adolescentes, responsáveis legais e profissionais de saúde. Aplicamos a lógica de pesquisa nas bases de dados Medline, Lilacs, Scopus, Science Direct, PsycINFO, Cochrane e Tripdatabase. Os artigos foram incluídos mediante descrição do desenvolvimento e teste psicométrico dos questionários de conhecimento em asma. Para os critérios de qualidade, a validade de conteúdo, validade de construto, consistência interna e reprodutibilidade foram avaliados e atribuída uma classificação “positivo”, “intermediário” ou “negativo”. Resultados: vinte e dois instrumentos foram incluídos. Nenhum deles teve uma avaliação positiva para todas as quatro propriedades psicométricas avaliadas. Seis receberam classificação “positivo” ou “intermediário”. Destes, somente um foi desenvolvido em português-BR. Conclusão: Atualmente, existem 22 questionários disponíveis para avaliar o nível de conhecimento da asma, mas maioria dos instrumentos não possui validação psicométrica complet

Severe lower respiratory tract infection in infants and toddlers from a non-affluent population: viral etiology and co-detection as risk factors

Abstract\ud \ud \ud \ud Background\ud \ud Lower respiratory tract infection (LRTI) is a major cause of pediatric morbidity and mortality, especially among non-affluent communities. In this study we determine the impact of respiratory viruses and how viral co-detections/infections can affect clinical LRTI severity in children in a hospital setting.\ud \ud \ud \ud Methods\ud \ud Patients younger than 3 years of age admitted to a tertiary hospital in Brazil during the months of high prevalence of respiratory viruses had samples collected from nasopharyngeal aspiration. These samples were tested for 13 different respiratory viruses through real-time PCR (rt-PCR). Patients were followed during hospitalization, and clinical data and population characteristics were collected during that period and at discharge to evaluate severity markers, especially length of hospital stay and oxygen use. Univariate regression analyses identified potential risk factors and multivariate logistic regressions were used to determine the impact of specific viral detections as well as viral co-detections in relation to clinical outcomes.\ud \ud \ud \ud Results\ud \ud We analyzed 260 episodes of LRTI with a viral detection rate of 85% (n = 222). Co-detection was observed in 65% of all virus-positive episodes. The most prevalent virus was Respiratory Syncytial Virus (RSV) (54%), followed by Human Metapneumovirus (hMPV) (32%) and Human Rhinovirus (HRV) (21%). In the multivariate models, infants with co-detection of HRV + RSV stayed 4.5 extra days (p = 0.004), when compared to infants without the co-detection. The same trends were observed for the outcome of days of supplemental oxygen use.\ud \ud \ud \ud Conclusions\ud \ud Although RSV remains as the main cause of LRTI in infants our study indicates an increase in the length of hospital stay and oxygen use in infants with HRV detected by RT-PCR compared to those without HRV. Moreover, one can speculate that when HRV is detected simultaneously with RSV there is an additive effect that may be reflected in more severe clinical outcome. Also, our study identified a significant number of children infected by recently identified viruses, such as hMPV and Human Bocavirus (HBov), and this is a novel finding for poor communities from developing countries.This study was supported by Abbott Laboratórios do Brasil Ltda (academic grant), from an unrestricted investigator-generated proposal

Instrumentos específicos para avaliar a qualidade de vida em crianças e adolescentes com asma

OBJETIVO: Identificar e descrever os instrumentos específicos que avaliam a QVRS de crianças e adolescentes com asma. FONTES DOS DADOS: Realizamos buscas nas bases de dados PubMed, Ovid e LILACS utilizando várias combinações de descritores (MeSH terms), selecionando artigos originais sobre desenvolvimento de questionários específicos de QVRS, publicados em inglês, português ou espanhol, entre 1990 e 2012. SÍNTESE DOS DADOS: Foram identificados 15 instrumentos que preencheram os critérios de inclusão. A maioria dos estudos avaliou confiabilidade mediante consistência interna e/ou reprodutibilidade e/ou sensibilidade às mudanças. A validade foi avaliada mediante a comparação com hígidos (validade discordante) ou análise fatorial. CONCLUSÕES: Dos 15 instrumentos, três são os mais utilizados, o PAQLQ, o PedsQL-Asthma e DISABKIDS. Em geral, estes três instrumentos possuem características psicométricas adequadas e são práticos de aplicar, mas apenas o PAQLQ completou a adaptação cultural para o Brasil

Cultural validation of the post-Liver transplant quality of life (pLTQ) questionnaire for the Brazilian population

Background and rationale. The post-Liver Transplant Quality of Life (pLTQ) questionnaire, developed in the United States, is a disease-targeted instrument designed to evaluate health-related quality of life (HRQoL) in liver transplant recipients. Our study sought to validate a version of the pLTQ for use in the Brazilian population. Translation and cross-cultural adaptation were carried out in accordance with international standard practices for questionnaire validation. Validity was measured by means of convergent validity (correlations between pLTQ domains and WHOQOL-Bref domains). Reliability was assessed by measurement of internal consistency (Cronbach’s alpha coefficient), reproducibility (intraclass correlation coefficient), sensitivity to change (effect size), and floor and ceiling effects.Results. The study sample comprised 160 liver transplant recipients, with a mean age of 56.9 ± 10.4 years, treated at a tertiary hospital in Southern Brazil. The sample was largely male (62.5%), and the predominant indication for liver transplant was hepatocellular carcinoma (49.4%). Only two questionnaire items were modified during the translation and cross-cultural validation stage. The mean total pLTQ score was 5.58 ± 0.9, with < 20% floor/ceiling effect. Correlations between pLTQ and WHOQOL-Bref domains were acceptable (r = 0.37 - 0.40). For similar dimensions, the correlations between WHOQOL-Bref and pLTQ were statistically significant (p ≤ 0.001). Cronbach’s alpha for the total score was 0.91 (95% CI 0.89 - 0.93), with a range of 0.51 to 0.77 across domains. Reproducibility was 0.90, and sensitivity to change was 0.84.Conclusion. In conclusion, the Brazilian Portuguese version of the pLTQ exhibited good psychometric performance, suggesting that it can be a useful tool in the Brazilian cultural context

Cultural Validation of the Transplanted Organ Questionnaire (TOQ) for the Brazilian Population

Background and rationale. The Transplanted Organ Questionnaire (TOQ), developed in France, is a disease-targeted instrument designed to evaluate what the transplanted organ represents to the recipient in patients who have undergone liver transplantation. The present study sought to validate a version of the TOQ for use in the Brazilian population. Translation and cross-cultural adaptation were carried out in accordance with international standard practices. Convergent validity was measured by correlations between TOQ domains and the Beck Depression Inventory (BDI), while reliability was assessed by measurement of internal consistency (Cronbach’s alpha coefficient), reproducibility (intraclass correlation coefficient), sensitivity to change (effect size), and floor and ceiling effects.Results. The study sample comprised 122 liver transplant recipients, with a mean age of 56.7 ± 9.9 years, treated at the outpatient clinic of a tertiary hospital in Southern Brazil. The sample was largely male (57.4%), and the predominant indication for liver transplant was hepatocellular carcinoma (34.4%). The mean total TOQ score was 32.9 ± 18.0. Cronbach’s alpha for the total score was 0.89 (95%CI 0.86-0.92). Correlations between TOQ and BDI domains were acceptable, with the rejection domain correlating most strongly (r = 0.37; p ≤ 0.001). In conclusion, the Brazilian Portuguese version of the TOQ exhibited good psychometric performance, suggesting that it can be a useful tool in the Brazilian cultural context

Bromopride, metoclopramide, or ondansetron for the treatment of vomiting in the pediatric emergency department: a randomized controlled trial

Objective: To compare the effectiveness of a single intramuscular dose of bromopride, metoclopramide, or ondansetron for treating vomiting. Methods: Randomized controlled trial including children 1–12 years of age presenting with acute vomiting at the pediatric emergency department. Outcomes: number of children that stopped vomiting at one, six, and 24 h following treatment; episodes of diarrhea; acceptance of oral liquids; intravenous rehydration; return to hospital and side effects. Results: There were 175 children who completed the study. Within the first hour after treatment, all drugs were equally effective, with ondansetron preventing vomiting in 100%, bromopride in 96.6%, and metoclopramide in 94.8% of children (p = 0.288). Within six hours, ondansetron was successful in preventing vomiting in 98.3% of children, compared to bromopride and metoclopramide, which were successful in 91.5% and 84.4% of patients, respectively (p = 0.023). Within 24 h, ondansetron was superior to both other agents, as it remained efficacious in reducing vomiting in 96.6% of children, as opposed to 67.8% and 67.2% with bromopride and metoclopramide, respectively (p = 0.001). The ondansetron group showed better acceptance of oral liquids (p = 0.05) when compared to the bromopride and metoclopramide. The ondansetron group did not show any side effects in 75.9% of cases, compared to 54.2% and 53.5% in the bromopride and metoclopramide groups, respectively. Somnolence was the most common side effect. Conclusions: A single dose of ondansetron is superior to bromopride and metoclopramide in preventing vomiting six hours and 24 h following treatment. Oral fluid intake after receiving medication was statistically better with Ondansetronwhile also having less side effects compared to the other two agents

Bromopride, metoclopramide, or ondansetron for the treatment of vomiting in the pediatric emergency department: a randomized controlled trial

Abstract Objective: To compare the effectiveness of a single intramuscular dose of bromopride, metoclopramide, or ondansetron for treating vomiting. Methods: Randomized controlled trial including children 1-12 years of age presenting with acute vomiting at the pediatric emergency department. Outcomes: Number of children that stopped vomiting at one, six, and 24 h following treatment; episodes of diarrhea; acceptance of oral liquids; intravenous rehydration; return to hospital and side effects. Results: There were 175 children who completed the study. Within the first hour after treatment, all drugs were equally effective, with ondansetron preventing vomiting in 100%, bromopride in 96.6%, and metoclopramide in 94.8% of children (p = 0.288). Within six hours, ondansetron was successful in preventing vomiting in 98.3% of children, compared to bromopride and metoclopramide, which were successful in 91.5% and 84.4% of patients, respectively (p = 0.023). Within 24 h, ondansetron was superior to both other agents, as it remained efficacious in reducing vomiting in 96.6% of children, as opposed to 67.8% and 67.2% with bromopride and metoclopramide, respectively (p = 0.001). The ondansetron group showed better acceptance of oral liquids (p = 0.05) when compared to the bromopride and metoclopramide. The ondansetron group did not show any side effects in 75.9% of cases, compared to 54.2% and 53.5% in the bromopride and metoclopramide groups, respectively. Somnolence was the most common side effect. Conclusions: A single dose of ondansetron is superior to bromopride and metoclopramide in preventing vomiting six hours and 24 h following treatment. Oral fluid intake after receiving medication was statistically better with Ondansetronwhile also having less side effects compared to the other two agents